(Q64607134)
Statements
Trabectedin for Recurrent Grade II or III Meningioma: a Randomized Phase II Study of the EORTC Brain Tumor Group (English)
0 references
July 2015
0 references
July 2017
0 references
90
0 references
18 year
0 references